[Skip to Navigation]
Sign In
Views 2,962
Citations 0
JAMA Network Clinical Guideline Synopsis
July 7, 2021

Review of Clinical Practice Guideline: Nosebleed (Epistaxis)

Author Affiliations
  • 1Division of Otolaryngology, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut
JAMA Surg. 2021;156(10):974-975. doi:10.1001/jamasurg.2021.2873

More than 60% of the US population have experienced epistaxis (nosebleeds) in their lifetime, of whom 6% will seek medical attention.1 Depending on the severity, nosebleeds can be costly and heavily affect quality of life.1 The range of interventions for epistaxis includes self-treatment and/or home remedies, moderately invasive (sometimes only temporizing) clinician-based interventions, and surgical or endovascular procedures. The American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) created this guideline for nosebleeds that are severe, persistent, and/or recurrent to provide clear, actionable recommendations and reduce variations in the management of epistaxis.

Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words